Drug Trial Radar · NCT00856596
Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females
Last checked: Nov 20, 2026Latest source record: Aug 6, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
Mar 2009
Primary completion
Aug 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Jamaica Hospital Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Johnson & Johnson
- First posted
- Mar 6, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The topical cream, Sertaconazole (Ertaczo), has been FDA approved for the treatment of athlete's foot using twice a day dosing for 4 weeks. This study wants to see if sertaconazole will work equally as well with once a day dosing for 4 weeks for athlete's foot.
Conditions
- Tinea Pedis
- Athlete's Foot
- Foot Fungus
- Ringworm
Interventions
Sertaconazole nitrate cream 2%Drug
Once a day topical cream
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare the efficacy and safety of sertaconazole 2% cream applied once a day for four weeks in the treatment of patients with KOH positive and culture positive symptomatic interdigital tinea pedis (athlete's foot).Time frame: Baseline visit, 1 week, 2 weeks, 4 weeks, 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jamaica Hospital Medical Center
Jamaica, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.